TLDR Two transplant patients on cyclosporine unexpectedly developed hair loss.
The document described two cases of alopecia areata (AA), a condition causing hair loss, in kidney-pancreas transplant recipients who were taking cyclosporine, an immunosuppressive drug. This finding was unexpected because cyclosporine is known to help treat AA due to its immunomodulatory effects. These two cases contribute to a small number of similar reports, totaling nine cases of AA in solid organ transplant recipients on cyclosporine. Both patients developed AA years after their transplant despite being on a stable dose of cyclosporine for over a year. Treatment with intralesional corticosteroids led to hair regrowth, but new AA patches appeared as the treated ones resolved. The paper highlights the complexity of AA's immunologic basis and the need for more research into the immune dysregulation associated with the disease.
12 citations,
November 2003 in “Journal of the American Academy of Dermatology” Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.
30 citations,
January 1999 in “Dermatology” Cyclosporine A can help some people with severe alopecia areata regrow hair.
12 citations,
November 1996 in “Australasian journal of dermatology” A kidney transplant patient on cyclosporin experienced unexpected severe hair loss, which improved with treatment adjustments.
January 2024 in “Journal der Deutschen Dermatologischen Gesellschaft” Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.
29 citations,
June 2013 in “Journal of the Saudi Society of Dermatology & Dermatologic Surgery” Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.
4 citations,
March 2023 in “Current Oncology” Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.
6 citations,
February 2021 in “Advances in Clinical and Experimental Medicine” Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.
10 citations,
January 2018 in “International Journal of Trichology” Mesalazine may help treat extensive alopecia areata effectively.
